Satisfaction With Semaglutide Driven by Effective Weight Loss

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 20, 2026.

via HealthDay

FRIDAY, Feb. 20, 2026 -- Satisfaction with semaglutide (Ozempic) is mainly driven by effective weight loss despite gastrointestinal side effects, according to a study published in the February issue of the Journal of Medical Internet Research.

Abanoub J. Armanious, from Rutgers Robert Wood Johnson Medical School in Piscataway, New Jersey, and colleagues applied a novel infoveillance approach to examine patient-reported experiences with off-label semaglutide use for weight loss in a study analyzing 60 publicly available, self-selected, anonymous user reviews.

The researchers identified three major themes from the thematic analysis: change in body weight and appetite, non-weight-related symptoms and side effects, and plan for ongoing use versus discontinuation. Reduced appetite, food cravings, or body weight were reported by two-thirds of respondents. Gastrointestinal complaints occurred frequently (reported by 37 of 60), but did not have a significant influence on satisfaction ratings or decisions to continue treatment. More frequent associations with low overall satisfaction and discontinuation were seen for minimal/no weight loss and the emergence of nongastrointestinal side effects. A greater willingness to continue semaglutide treatment was seen in association with effective weight loss, even when accompanied by gastrointestinal side effects.

"What we found is that for many users, the calculus is straightforward: If the drug helps them lose weight, they're willing to tolerate significant discomfort," senior author Morgan H. James, Ph.D., also from Rutgers Robert Wood Johnson Medical School, said in a statement. "That tells us something important about the demand for effective weight loss options and how we need to think about supporting such patients."

One author is an inventor on a patent describing novel approaches for reducing overeating.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-02-21 15:58

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords